Hitachi Healthcare Americas


Hitachi Healthcare News
July 13, 2015 - Hitachi Aloka Medical at ASE 2015
March 30, 2015 - Hitachi Aloka Medical, Ltd. and iVu Imaging Corp Announce Exclusive Agreement for Global Distribution of iVu's SOFIA Automated Whole Breast Ultrasound Scanner
December 17, 2014 - Hitachi Aloka Medical America Expands its Sales Force to Address Point of Care Market
December 16, 2014 - Hitachi Aloka Medical America and iVu Imaging Corp Announce Exclusive Agreement for Distribution of Sofia Whole Breast Ultrasound System
May 14, 2013 - Olympus Endoscopes Now Powered by Next-Generation Ultrasound Processor
April 15, 2013 - Hitachi Aloka Medical, Ltd. Announces the New F37 Ultrasound System
June 20, 2011 - Hitachi Aloka Medical, Ltd. Announces U.S. Ultrasound Division Organization
March 29, 2011 - Henry Ford pioneers robotically controlled ultrasound
November 16, 2010 - An ALOKA First: ALOKA’s Surgical Ultrasound Probes Compatible with All STERRAD Sterilization Systems
October 5, 2010 - Auto NT and pre-calibrated machines could improve the detection of chromosomal disease
May 13, 2010 - ALOKA Ultrasound's ProSound Alpha 6 Wins International Design Award
May 12, 2010 - ALOKA Ultrasound Announces U.S. Debut of ProSound Alpha 6
August 28, 2009 - Aloka Announces New ProSound Alpha Series Ultrasound System
April 2, 2008 - Aloka Introduces ProSound 3500SX
November 2, 2007 - ALOKA to introduce new “ProSound” Diagnostic Ultrasound Systems
October 8, 2007 - Aloka Unveils New ProSound Ultrasound Systems
October 4, 2007 - ALOKA ULTRASOUND RANKED #1
August 20, 2007 - Aloka and RFA Agreement

Aloka and RFA Agreement

August 20, 2007

Aloka Ultrasound and RFA Medical Combine Efforts to Bring State-of-the-Art Technology to the Operating Room

WALLINGFORD, CT - Aloka Ultrasound (Wallingford, CT) and RFA Medical (Fremont, CA) have agreed to combine efforts in promoting their respective medical devices used for ablative procedures. Aloka’s ultrasound technology is the imaging modality used to guide the placement of RFA Medical’s HS-RFA™ bi-polar radio frequency ablation device during ablative procedures.

Aloka and RFA Medical expect the alliance to increase and broaden awareness among surgeons of the important benefits provided by each company’s complementary products. Each company will retain direct control of the sales process for their individual devices.

Aloka’s Chief Operating Officer David Famiglietti commented, “We are excited to be working with RFA Medical as a way to further strengthen our leadership position in the IOUS™ (Intraoperative Ultrasound) market. We are extremely impressed with the advancements RFA Medical has made in the area of bi-polar radio frequency ablation with their HS-RFA™ technology, and especially pleased that they chose to design their laparoscopic device to operate with Aloka’s exclusive end-fire laparoscopic transducer. We look forward to a long-term and mutually beneficial relationship with RFA Medical.”

RFA Medical’s President Steven Daniel went on to say “We are also delighted to be working with such a progressive and forward-looking company as Aloka. We feel that together we can bring the technological benefits from both companies to our mutual current and future customers so that they can better care for their patients.”

About Aloka

Aloka Company, Ltd. (TSE: 7704)—The Innovator in Ultrasound—has served the worldwide medical community for more than 50 years. As one of the longest continuously operating ultrasound companies in the world, Aloka is one of the most experienced and innovative firms in the diagnostic ultrasound market with more than 200,000 ultrasound systems installed worldwide. Aloka’s U.S. headquarters is located in Wallingford, CT.

About RFA Medical

RFA Medical, Inc. is a privately held medical device company specializing in the area of oncology including devices for high speed bi-polar radio frequency ablation incorporating proprietary HS-RFA™ technology and devices for the pre-coagulation of tissue prior to resections. RFA Medical’s headquarters is located in Fremont, CA.

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements, the accuracy of which is necessarily subject to risks and uncertainties. Discussions regarding physician adoption, performance of the system, and other matters discussed in this release, may differ significantly from the discussion of such matters in the forward-looking statements. Such differences may be based upon factors such as strategic planning decisions by management, regulatory requirements, re-allocation of internal resources, decisions by insurance companies, scientific advances by third parties, and introduction of competitive products, as well as those factors set forth in the Company's most recent Reports.

News & Events


Contact Info

Main Number
Direct: 1-330-425-1313
Toll Free: 1-800-800-3106